Sydney to undertake clinical studies of needle-free vaccine patch

University of Sydney researchers have been awarded $1.12 million in funding via the Innovative Manufacturing CRC (IMCRC) to undertake independent clinical research studies to understand the potential of needle-free vaccine delivery for at-risk groups. This grant reflects matched funding from Commonwealth Government funded IMCRC and Vaxxas, an Australian biotechnology company.

The two upcoming clinical studies are designed to evaluate the safety, feasibility, acceptability and usability of self-administration of Vaxxas’ vaccine delivery technology using an inactive substance. They will focus on older adults and healthcare professionals who are more likely to be impacted by pandemic influenza and SARS-COV-2.